Mesenchymal stem cells (MSCs) are largely entrapped in the lungs after intravenous delivery. The underlying mechanisms have been poorly understood. Flow cytometry and Western blot analysis showed that the expression levels of many integrins such as b1, a5, and aVb3 in MSCs increased markedly upon cultured expansion in 2D monolayers, whose ligands fibronectin and vitronectin were detected on the surface of vascular endothelial cells in the lungs by immunostaining and flow cytometry. Blockade of integrin b1, integrin a5, or integrins aVb3 with functional blocking antibodies significantly decreased the amount of MSCs entrapped in the lungs following intravenous infusion as determined by real-time PCR and histological analysis; meanwhile, corresponding increases in the levels of circulating MSCs in the blood and MSCs homed to the ischemic myocardium and inflamed ear were found. Intriguingly, a short period of 3D spheroid culture of MSCs, which had been expanded for several passages in monolayers, substantially reduced the expression levels of many integrins and the number of MSCs entrapped in the lungs. Our results indicate that the excess expression and activation of integrins is a significant cause of lung entrapment of MSCs. STEM CELLS 2015;33:3315-3326
SIGNIFICANCE STATEMENTMesenchymal stem cells (MSCs) have shown profound therapeutic potential in tissue repair=regeneration, and intravenous infusion has been a popular translation route of the cells for its convenience and safety. However, recent studies indicate that MSCs are largely entrapped in lungs after intravenous delivery and die shortly. The underlying mechanisms have been poorly understood. In this study, we provide evidence to show that excess expression and activation of integrins in MSCs that are developed during conventional monolayer culture is a critical cause of MSC entrapment in the lungs. Our study suggests a novel approach to increase MSC homing and engraftment to sites of tissue injuries by reducing the ECM binding activity of surface integrins.